A new trading day began on Friday, with Sagimet Biosciences Inc (NASDAQ: SGMT) stock price down -3.95% from the previous day of trading, before settling in for the closing price of $8.61. SGMT’s price has ranged from $1.73 to $8.78 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -74.49%. With a float of $23.62 million, this company’s outstanding shares have now reached $30.67 million.
Let’s determine the extent of company efficiency that accounts for 14 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sagimet Biosciences Inc (SGMT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Sagimet Biosciences Inc is 26.63%, while institutional ownership is 36.23%. The most recent insider transaction that took place on Jul 23 ’24, was worth 74,830. In this transaction Executive Chairman of this company sold 23,625 shares at a rate of $3.17, taking the stock ownership to the 118,693 shares. Before that another transaction happened on Jul 19 ’24, when Company’s Chief Medical Officer sold 8,357 for $3.10, making the entire transaction worth $25,910. This insider now owns 81,213 shares in total.
Sagimet Biosciences Inc (SGMT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -74.49% per share during the next fiscal year.
Sagimet Biosciences Inc (NASDAQ: SGMT) Trading Performance Indicators
Here are Sagimet Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 20.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.78, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -3.08 in one year’s time.
Technical Analysis of Sagimet Biosciences Inc (SGMT)
Looking closely at Sagimet Biosciences Inc (NASDAQ: SGMT), its last 5-days average volume was 4.06 million, which is a jump from its year-to-date volume of 1.13 million. As of the previous 9 days, the stock’s Stochastic %D was 85.65%. Additionally, its Average True Range was 0.75.
During the past 100 days, Sagimet Biosciences Inc’s (SGMT) raw stochastic average was set at 83.10%, which indicates a significant increase from 78.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 151.62% in the past 14 days, which was higher than the 114.46% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.50, while its 200-day Moving Average is $4.15. However, in the short run, Sagimet Biosciences Inc’s stock first resistance to watch stands at $9.35. Second resistance stands at $10.42. The third major resistance level sits at $11.25. If the price goes on to break the first support level at $7.45, it is likely to go to the next support level at $6.62. Now, if the price goes above the second support level, the third support stands at $5.55.
Sagimet Biosciences Inc (NASDAQ: SGMT) Key Stats
With a market capitalization of 253.68 million, the company has a total of 30,675K Shares Outstanding. Currently, annual sales are 0 K while annual income is -45,570 K. The company’s previous quarter sales were 0 K while its latest quarter income was -18,180 K.
